- Systematic review and meta-analysis of five placebo-controlled RCTs (335 participants) testing perioperative pregabalin in adults undergoing elective lumbar spine surgery.
- Pregabalin was compared with placebo, with the primary outcome being pain intensity at 3 months, pooled across four trials (275 participants).
- Pregabalin did not reduce 3-month pain intensity (SMD 0.03, 95% CI -0.41 to 0.47; I² 69%; low certainty).
- Functional disability was lower with pregabalin (SMD -0.51, 95% CI -0.86 to -0.16), but the differences fell below minimal important change thresholds, with very low certainty.
Perioperative medicine
Research from anesthesiology, pain and critical care journals, sourced from PubMed.
Sorted by publication date, not import date. Recent filters exclude papers with only a publication year; find those under All years.
AI-generated abstract summaries can contain errors. Verify findings against the original paper before applying them to patient care.
Last successful paper check: 16 Nov 2026 17:18 UTC.
0 newly discovered papers saved; these are not necessarily published today.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
2 papers awaiting AI summaries. Summary processing had an error; paper-fetch status is separate.
Background checks run while the server is active. This does not guarantee a daily run if hosting sleeps.
- Systematic review and meta-analysis of seven retrospective cohorts (28,525 patients) comparing lumbar fusion patients with and without preoperative GLP-1RA exposure.
- Six of the seven studies used propensity score matching or another matching strategy to balance the comparison groups.
- No significant association with reoperation or revision (OR 0.74, 95% CI 0.44-1.24; P = 0.25) or postoperative infection (OR 0.83, 95% CI 0.68-1.00; P = 0.05).
- The authors found no signal of increased postoperative risk and called for prospective studies with standardized exposure definitions and perioperative management protocols.
- Systematic review and meta-analysis of 20 studies (n=1979, 11 countries) assessing the furosemide stress test in critically ill adults and children with acute kidney injury.
- For AKI progression, pooled sensitivity was 0.69 and specificity 0.88 (AUC 0.89), with a low-certainty GRADE rating.
- For KRT initiation, sensitivity was 0.81 and specificity 0.75 (AUC 0.79), while mortality prediction was weaker, with sensitivity 0.56 and specificity 0.76.
- FST-guided early KRT initiation had an uncertain effect on short-term mortality (RR 1.00, 95% CI 0.79-1.27; two RCTs, n=212; very low certainty).
- Systematic review and meta-analysis of 58 comparative studies, including 13,530 patients, given fibrinogen concentrate for acquired hypofibrinogenaemia.
- FC was compared with all other treatments, with separate analyses for adult and paediatric patients.
- Adult FC recipients received fewer red cell (IRR 0.72; 95% CI 0.59-0.89; P=0.002), plasma (IRR 0.69; 95% CI 0.54-0.89; P=0.004), and platelet units (IRR 0.56; 95% CI 0.33-0.95; P=0.03).
- No significant difference in mortality or thromboembolic events was found in adults, and the authors concluded FC can reduce adult transfusions without obvious safety concerns.
- Systematic review of three randomized controlled trials including 168 adults with type 2 diabetes undergoing cardiac surgery.
- Compared liraglutide added to insulin with insulin alone or placebo, assessing perioperative glucose, variability, insulin adjustments, and hypoglycemia.
- Liraglutide was associated with lower glucose, reduced glycemic variability, and fewer insulin adjustments, with low hypoglycemia, though the abstract reports no effect sizes or p values.
- Nausea and vomiting were more frequent with liraglutide; the authors call the evidence preliminary and call for larger, standardized trials with long-term outcomes.
- Systematic review and meta-analysis of 19 randomized controlled trials (n = 4,742) comparing neuraxial and general anesthesia in adults undergoing hip fracture surgery.
- Neuraxial anesthesia was compared with general anesthesia across mortality, delirium, cardiac and pulmonary complications, kidney injury, length of stay, and PONV.
- Neuraxial anesthesia was associated with lower intraoperative hypotension (RR 0.55, 95% CI 0.40-0.77), acute kidney injury (RR 0.57, 95% CI 0.38-0.84), and shorter hospital stay (MD -0.58 days, 95% CI -1.08 to -0.07).
- No significant differences were found for mortality at any time point, delirium, ACS, pneumonia, or PONV, and heterogeneity was substantial for some outcomes.
- Bayesian random-effects meta-analysis of 15 randomized trials in major noncardiac surgery, comparing protocolized intraoperative arterial pressure targeting with usual care or lower-pressure approaches.
- Pooled outcomes were all-cause mortality (primary), acute kidney injury, and myocardial injury after noncardiac surgery (MINS).
- Mortality was centered on an OR of 1.00 (95% CI 0.83-1.21), AKI showed OR 0.87 (95% CI 0.73-1.03), and MINS showed OR 1.04 (95% CI 0.93-1.15).
- The authors found no consistent benefit over usual care; AKI estimates were most favorable but uncertain and sensitive to excluding individual trials.
- Systematic review and network meta-analysis of 96 RCTs (N=7396) comparing exercise prehabilitation interventions and their components before surgery.
- Combined aerobic, pulmonary, and functional exercise was most likely to reduce complications (P-score 0.94; OR 0.16, 95% CI 0.05-0.60; very low certainty).
- Combined aerobic, pulmonary, and functional exercise was also most likely to shorten length of stay (P-score 0.97; MD -3.4 days, 95% CI -5.7 to -1.0; moderate certainty).
- Combined aerobic and strength exercise ranked highest for health-related quality of life (SMD 0.67, 95% CI 0.07-1.27; low certainty), while no intervention significantly improved physical recovery.
- Systematic review of 207 randomized controlled trials including 63,785 adults undergoing cardiac surgery, evaluating 55 pharmacological and non-pharmacological interventions to prevent cardiac surgery-associated acute kidney injury.
- Most included trials were small (median sample size 120) and single-center (76.7%), and most reported neutral results (149 of 206).
- Dexmedetomidine (OR 0.48, 95% CI 0.29-0.80), fenoldopam (OR 0.57, 95% CI 0.33-0.98), nitric oxide (OR 0.61, 95% CI 0.43-0.88), and remote ischemic preconditioning (OR 0.78, 95% CI 0.67-0.90) were associated with lower odds of CSA-AKI.
- The authors conclude that only a limited number of interventions were associated with lower odds of CSA-AKI and that these findings need cautious interpretation and confirmation in adequately powered RCTs.
- Systematic review and meta-analysis of 27 randomized controlled trials including 3041 patients undergoing surgery, searched from inception to December 2025.
- Perioperative vitamin C was compared with control; the review pooled effects on pain, opioid use, rescue analgesia, nausea and vomiting, and CRPS-1.
- Vitamin C reduced pain at 24 h (SMD -0.69, 95% CI -0.98 to -0.40) and 24-h morphine use (MD -4.25 mg, 95% CI -6.14 to -2.35), with rescue analgesia also reduced (RR 0.63, 95% CI 0.47 to 0.84).
- Authors say evidence may support reduced acute pain and opioid use with a favorable safety profile, but heterogeneity and publication bias limit it, and routine recommendation is not yet supported; CRPS-1 risk was lower in high-risk orthopedic patients (RR 0.36, 95% CI 0.23 to 0.58).
- Systematic review and meta-analysis of 12 randomised trials (n = 739) comparing remimazolam with sevoflurane for general anaesthesia maintenance or deep sedation.
- Remimazolam was compared with sevoflurane, with outcomes covering intraoperative haemodynamic stability and postoperative nausea and vomiting.
- Remimazolam reduced the risk of intraoperative hypotension versus sevoflurane, RR 0.38 (95% CI 0.25 to 0.57; P < 0.001).
- MAP and heart rate differences appeared only at specific time points, and the PONV reduction came from sensitivity analyses, not the primary analysis.
- Systematic review and meta-analysis of 4 RCTs (7 reports, 446 randomized adults) comparing perioperative subcutaneous liraglutide with placebo or insulin-based usual care in cardiac surgery.
- Liraglutide was compared with placebo or insulin usual care, with glycemic efficacy and hypoglycemia risk as the central questions.
- Liraglutide did not change 30-day mortality (1/161 vs 3/160; RR 0.42, 95% CI 0.06-2.81) or the composite postoperative complication outcome (RR 0.92, 95% CI 0.74-1.14).
- Hypoglycemia was similar (8/165 vs 9/166; RR 0.85, 95% CI 0.34-2.13), and nausea/vomiting estimates were very imprecise (RR 3.01, 95% CI 0.26-35.27).
- Systematic review and meta-analysis of 55 observational studies, with 21 contributing to the meta-analyses, in acutely admitted adult ICU patients.
- Exposure was pre-admission frailty or functional dependency, compared with non-frail or independent status.
- Non-frail versus frail participants had RR 0.62 (95% CI 0.58-0.67, P<0.01) for all-cause mortality; independent versus dependent had RR 0.47 (95% CI 0.40-0.54, P<0.01).
- The authors conclude that frailty and dependency were associated with higher mortality, but certainty of evidence was very low and heterogeneity was substantial.
- Systematic review and meta-analysis of 21 randomized controlled trials including 1271 adults undergoing spinal surgery.
- The exposure was perioperative intravenous magnesium sulfate, with a control group for comparison.
- Magnesium reduced 24-hour pain scores (MD -0.55, 95% CI -1.01 to -0.10, P = 0.02) and opioid consumption (MD -4.95 mg, 95% CI -8.74 to -1.15 mg, P = 0.01).
- Magnesium was associated with less postoperative nausea and vomiting but more hypotension, and with prolonged time to follow commands and recover orientation.
- Systematic review and meta-analysis of 27 studies (n = 21,908) of children under 18 undergoing noncardiac surgery, assessing KDIGO-defined AKI within 7 postoperative days.
- Pooled incidence was reported separately by population because overall pooling was judged uninterpretable given heterogeneity (I² = 98.7%).
- Reported incidence was 22.3% (95% CI 11.2-39.3) after neonatal surgery, 30.1% (95% CI 21.4-40.6) after pediatric liver transplantation, and 9.2% (95% CI 3.3-23.6) in mixed pediatric surgical populations.
- Within mixed surgical populations, AKI rose with higher ASA class (2.4% in ASA 1-2 to 18.9% in ASA 4-5) and fell with age; the authors conclude the true incidence remains uncertain, with certainty rated low to very low.
- Systematic review and meta-analysis of 15 RCTs including 3,274 older adults undergoing cardiac surgery.
- Perioperative dexmedetomidine was compared with placebo or alternative sedative or analgesic regimens for preventing postoperative delirium.
- Dexmedetomidine lowered postoperative delirium incidence (RR 0.70, 95% CI 0.56 to 0.86, p = 0.001; moderate certainty) but increased reported bradycardia (RR 2.08, 95% CI 1.31 to 3.31).
- The benefit appeared larger against active comparators than placebo or saline. The delirium duration reduction (MD -1.12 days) was low certainty with high heterogeneity.
- Systematic review and meta-analysis of eight retrospective cohort studies, covering 311,402 ACDF patients including 8,182 GLP-1RA users matched to non-users.
- Compared perioperative GLP-1RA use with non-use for pseudarthrosis, reoperation, dysphagia, deep vein thrombosis, and readmission after ACDF.
- Lower pseudarthrosis odds at 6 months (OR 0.60, 95% CI 0.52 to 0.71), 12 months (OR 0.62, 0.53 to 0.73), and 24 months (OR 0.67, 0.57 to 0.79).
- Findings for reoperation, dysphagia, deep vein thrombosis, and readmission were heterogeneous and inconsistent, so evidence on other complications is inconclusive.
- Systematic review and meta-analysis of 30 supervised and 12 unsupervised aerobic exercise studies, including 3157 and 1848 adult clinical patients.
- Compared supervised and unsupervised moderate-to-high-intensity aerobic exercise, each against controls; no included study directly compared the two supervision modes.
- Supervised exercise was associated with higher peak oxygen consumption (cumulative mean difference 0.88 ml/min/kg, 95% CI 0.49-1.27) and fewer complications (OR 0.60, 95% CI 0.39-0.93, P=0.026).
- Both supervised and unsupervised exercise improved 6MWT distance, and the authors note that the lack of direct comparisons limits the findings.
- A systematic review of 39 studies examined how different surgical procedures change disability measured by the WHODAS 2.0 questionnaire.
- Pre-operative disability ranged from 2% to 61%, and in 21 studies disability rose by 1% to 17% within 3 months of surgery.
- Orthopaedic studies reported 10-37% reductions in disability within 3 months, while cancer surgery studies reported small 1-8% increases.
- The authors found 13 different endpoints and three disability thresholds across studies, and called for standardised reporting of disability outcomes.
- Systematic review and meta-analysis of 12 RCTs including 713 adult cardiac surgery patients undergoing cardiopulmonary bypass.
- Compared intraoperative haemoadsorption inserted into the bypass circuit with conventional bypass without haemoadsorption.
- No significant mortality benefit was found (OR 1.08, 95% CI 0.59-2.01, P=0.75), and no significant difference in hospital or ICU length of stay.
- Authors conclude there was no evidence of clinical benefit for routine use, but clinically relevant benefit or harm cannot be excluded, and only one included study had low risk of bias.
- This systematic review screened ERAS Society guidelines, including 24 guidelines from 39 publications dated 2013 to 2025, for anaesthesiological recommendations.
- Each guideline's anaesthesiological recommendations were classified across 45 umbrella terms by consistency of recommendation across guidelines, with AGREE II used to rate methodological quality.
- Eight terms were consistent, including multimodal analgesia, fasting, and thromboprophylaxis, while 16 were mixed and 11 were sparse; mean AGREE II score was 76%.
- The authors argue a consistent anaesthesiological core exists, and flag mixed-strength, high-frequency domains such as fluid management for structured local appraisal.
- This NATA consensus document combines a systematic review of evidence on intravenous iron safety with expert recommendations.
- It covers intravenous iron for iron deficiency and iron-deficiency anaemia, focusing on adverse events rather than comparing specific treatments.
- Adverse events addressed include hypersensitivity and infusion reactions, hypophosphataemia, extravasation, and potential infection risk.
- The authors offer practical guidance on diagnosing adverse events, mitigating risk, counselling patients, and selecting formulations.
- Systematic review and Bayesian network meta-analysis of 13 studies, covering 54 models and 927,113 patients undergoing non-cardiac surgery.
- Machine learning models were compared with the Revised Cardiac Risk Index, analysing the best and worst version of each model type.
- Automated machine learning ranked highest (SUCRA 96.6; best-version MD 0.28, 95%CrI 0.16-0.40), and gradient boosting also outperformed the Revised Cardiac Risk Index (MD 0.20, 95%CrI 0.14-0.26).
- The authors conclude that most machine learning models discriminate better than traditional scores, but none were externally validated, only six had low risk of bias, and prospective multicentre evaluation is needed.
- Systematic review and meta-analysis of 17 randomized controlled trials including 1871 children undergoing surgery, comparing music with no-music controls.
- Music was compared with no-music controls across preoperative anxiety, postoperative pain, heart rate, and blood pressure outcomes.
- Music significantly reduced preoperative anxiety (SMD -2.03, 95% CI -3.19 to -0.86) and postoperative pain (SMD -0.64, 95% CI -1.01 to -0.27).
- Heart rate and mean arterial pressure also fell (MD -12.92 bpm; MD -8.41 mmHg), with no significant effect on systolic pressure.
- Systematic review and meta-analysis of 20 studies including nearly 800,000 adult cardiac surgery patients.
- Compared ultra-fast-track extubation (in the OR or within 1 hour) with fast-track extubation (within 6 hours in the ICU).
- UFTE was linked to lower 30-day mortality (OR 0.54), shorter ICU stay (MD -12.27 hours) and shorter hospital stay (MD -1.19 days).
- In propensity-matched cohorts, mortality and reintubation were comparable, though shorter stays persisted, and the authors call for randomized trials.
- This systematic review and meta-analysis pooled 32 studies of 3142 patients, including six diagnostic, 22 prognostic, and four studies reporting both.
- Diagnostic studies were not pooled, but individual studies suggested sensitivity of 78-95% and specificity of 80-90% for detecting raised central venous and right atrial pressure.
- In cardiac patients, VExUS of at least 2 was associated with acute kidney injury (OR 4.44, 95% CI 2.34-8.43) and mortality (OR 3.17, 95% CI 1.30-7.75), while in critically ill patients no association was found for either outcome.
- The authors conclude VExUS has moderate to good accuracy for raised central venous and right atrial pressure, and that its link to outcomes is clearer in cardiac than in critically ill patients; per-patient VExUS 3 was associated with mortality across all patients.
- Systematic review and meta-analysis of 15 randomized trials (15,603 patients) comparing higher versus routine intraoperative blood pressure targets in adults undergoing elective noncardiac surgery under general anesthesia.
- Higher targets, either fixed absolute thresholds or personalized to preoperative baseline, were compared with routine blood pressure management.
- Higher targets did not reduce acute kidney injury (RR 0.95; 95% CI 0.85 to 1.06) or acute myocardial injury (RR 1.02; 95% CI 0.94 to 1.12), and mortality was unchanged (RR 1.00; 95% CI 0.75 to 1.34).
- A reduction in postoperative delirium was seen (RR 0.73; 95% CI 0.54 to 0.98), but trial sequential analysis judged this cumulative evidence insufficient, so the authors call for confirmation in adequately powered trials.
- Meta-analysis of 114 trials with 13,951 surgical patients, mostly low risk of bias, with nearly all HES administration limited to under 24 hours.
- Trials used HES 130/0.4 or 130/0.42 in surgical patients, with acute kidney injury and preoperative-to-postoperative creatinine change as the focus.
- HES did not significantly increase acute kidney injury (RR 1.02; 95% CI 0.91 to 1.16), and creatinine change was -0.62 µmol/l (95% CI -3.82 to 2.57 µmol/l).
- The authors conclude that current HES solutions do not provoke renal injury in surgical patients, and trial sequential analysis supported noninferiority for creatinine change.
- Systematic review and meta-analysis of five randomized controlled trials, including 646 adults undergoing brain surgery, with searches run through April 2025.
- Evaluated perioperative dexmedetomidine, given as a loading dose followed by a maintenance infusion, for preventing postoperative delirium.
- The pooled risk ratio was 0.47 (95% CI 0.35-0.63; p < 0.00001), a 53% reduction in delirium risk, with no heterogeneity (I2 = 0%).
- Subgroups showed similar effects across brain tumor and other cranial procedures, adverse events were comparable and mostly mild, and the authors call for multicenter trials.
- Systematic review and meta-analysis of 25 studies including 116,815 surgical patients, with 12 RCTs (n = 845) in the primary analysis.
- Compared perioperative intravenous methadone with other opioids, with respiratory depression defined as naloxone use, respiratory rate under 8/min, or SpO2 under 90%.
- Respiratory depression occurred in 7.7% of methadone patients versus 6.6% of controls, RR 1.22 (95% CI 0.76-1.95), which was not significant.
- The authors found no higher risk with methadone, but rated certainty of evidence as very low, and most data came from retrospective datasets.
- Systematic review and meta-analysis of 20 studies including 19,918 patients undergoing lung resection surgery.
- Evaluated goal-directed fluid therapy as a preventive strategy and linked acute kidney injury to postoperative outcomes.
- Pooled AKI incidence was 5.31% (95% CI, 3.61%-6.70%); AKI was tied to longer stay (MD 0.92 days; 95% CI, 0.52-1.30) and short-term mortality (RR 5.60; 95% CI, 1.66-18.83).
- Goal-directed fluid therapy did not significantly reduce AKI risk (RR 0.64; 95% CI, 0.32-1.27), and the authors call AKI a prognostic indicator warranting early risk stratification.
- Systematic review and meta-analysis of 21 studies including 5725 surgical patients aged 18 or older, with 11 non-cardiac and 10 cardiac surgery studies, searched to March 2024.
- Pooled preoperative prevalence of impairment was compared across six cognitive domains, and perioperative changes in those domains were examined.
- Preoperative impairment was highest in executive function at 18% (95% CI, 13%-24%), followed by visuospatial function at 16% and attention/working memory/processing speed at 14%.
- Postoperative impairment peaked at 1 week (attention 35%, 95% CI 4%-66%) and fell by 3 months, with some confidence intervals crossing zero.
- Systematic review and meta-analysis of 9 randomized controlled trials with 672 patients undertaking VATS, drawn from 31 identified studies.
- Intravenous lidocaine was compared with control, with bolus and infusion regimens varying across trials.
- Lidocaine did not reduce 24-hour (5 trials, n = 328) or 48-hour (3 trials, n = 242) postoperative morphine use, or pooled movement pain scores.
- Lidocaine significantly reduced postoperative nausea and vomiting across 5 trials (n = 360) with negligible heterogeneity, and the authors judged it safe.
- Systematic review and meta-analysis of 16 randomized controlled trials including 1133 patients undergoing cardiac surgery with cardiopulmonary bypass.
- Compared intraoperative hemoadsorption using sorbent devices during bypass with bypass conducted without hemoadsorption.
- Hemoadsorption significantly reduced acute kidney injury incidence (RR 0.75; 95% CI 0.59-0.96; p = 0.020).
- Renal replacement therapy, mortality and secondary outcomes showed no significant differences, and the authors call for studies on clinical relevance and patient selection.
- Systematic review and meta-analysis of 19 studies (n = 11,667) of older adults undergoing major cardiac procedures, across four continents.
- Preoperative frailty, identified with validated tools such as the Fried phenotype or Clinical Frailty Scale, was compared with postoperative outcomes; overall prevalence was 16.8%.
- Frailty was associated with delirium (OR 4.11; 95% CI 2.00-8.45), infection (OR 3.72; 95% CI 2.27-6.12), and renal complications (OR 2.72; 95% CI 2.05-3.60), all P <.001.
- Frailty was also linked to longer hospital and ICU stays and to 30-day (OR 3.58) and 1-year (OR 2.25) mortality; the authors suggest routine frailty screening.
- Systematic review and meta-regression of 99 randomized trials (n = 8222) in adults undergoing major elective surgery.
- Pooled exercise prehabilitation against control across procedures, participants, and programs, with prespecified effect modifiers examined.
- Prehabilitation was associated with fewer complications (OR 0.54; 95% CI 0.44-0.67; moderate certainty) and shorter stay (MD -0.90 days; 95% CI -1.23 to -0.58; low certainty).
- Inspiratory muscle training was the only significant effect modifier for both outcomes, at low certainty, and the authors call for individual participant data to clarify factors.